Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei

doi:10.4292/wjgpt.v7.i3.434

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

This Article

(311)

(386)

(0)

(5511)

(4)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Gastrointest Pharmacol Ther. Aug 6, 2016; 7(3): 434-439
Published online Aug 6, 2016. doi: 10.4292/wjgpt.v7.i3.434

Table 2 Clinicopathological characteristics of patients with and without leukopenia

	Leukopenia	No leukopenia
No.	10	32
Gender
Male	3	16
Female	7	16
Age (yr)	60 ± 16	48.5 ± 11
MMC	10	22
OX/5-FU	0	10
Splenectomy	2	12
Hospital stay (d)	25 ± 12	20 ± 10
Length of operation (h)	08:54 ± 01:44	09:48 ± 02:28
HAP	2	0
SSI	1	1
PE	2	2
IAA	0	1
UTI	1	0

HAP: Hospital-acquired pneumonia; SSI: Surgical site infections; IAA: Intraabdominal abscess formation; PE: Pleural effusion; UTI: Urinary tract infection; MMC: Mitomycin C; OX/5-FU: Oxaliplatin/5-fluorouracil.

Full Size Table

Citation: Horvath P, Beckert S, Struller F, Königsrainer A, Königsrainer I. Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei. World J Gastrointest Pharmacol Ther 2016; 7(3): 434-439
URL: https://www.wjgnet.com/2150-5349/full/v7/i3/434.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v7.i3.434

Horvath P, Beckert S, Struller F, Königsrainer A, Königsrainer I. Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei. World J Gastrointest Pharmacol Ther 2016; 7(3): 434-439 [PMID: 27602245 DOI: 10.4292/wjgpt.v7.i3.434]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.